Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Pfizer's 7.5% Dividend: Income Haven or House of Cards?
Pfizer's 7.5% Dividend: Income Haven or House of Cards?
[content-module:CompanyOverview|NYSE:PFE]

A dividend yield that surpasses 7.5% from a pharmaceutical sector giant like Pfizer Inc. (NYSE: PFE) certainly catches the eye of income-seeking

ProSiebenSat1 Stock: Takeover Drama Intensifies After Rejection
ProSiebenSat1 Stock: Takeover Drama Intensifies After Rejection

The corporate leadership of ProSiebenSat.1 has firmly rejected MediaForEurope's (MFE) takeover offer, deeming it financially inadequate at approximately €5.75 per share. This decision, however

Newell's Innovations & Other Strategies Encouraging: Apt to Hold
Newell's Innovations & Other Strategies Encouraging: Apt to Hold

Newell Brands Inc. NWL appears well-poised for growth on the back of its robust business strategies. Management has been evaluating opportunities to optimize the category mix and drive growth within

CI's Unit Unveils Offering to Expand Access to GLP-1 Medications
CI's Unit Unveils Offering to Expand Access to GLP-1 Medications

The health services arm of The Cigna Group CI, Evernorth, recently introduced a pharmacy benefit offering designed to enhance access to the weight loss medications WEGOVY and ZEPBOUND. This

3 Trades Members of Congress Are Making Right Now
3 Trades Members of Congress Are Making Right Now

Whether or not members of Congress should be allowed to buy or sell stocks is another topic. Retail investors should keep their eyes on the ball. That means, if investors can’t beat them, they may

3 Best Breakout Stocks to Add to Your Portfolio Right Away
3 Best Breakout Stocks to Add to Your Portfolio Right Away

An active investing strategy involves searching for breakout stocks in a specific price range. When choosing breakout stocks, consider selling if the price falls below the lower band and holding for

TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
[content-module:CompanyOverview|NYSE:TJX]

TJX Companies (NYSE: TJX) stock price stumbled in the wake of its Q1 earnings report and guidance update, but investors should not fret. The move is a

Whatever Happened to Pandemic Stocks? Some Are Showing Life Again
Whatever Happened to Pandemic Stocks? Some Are Showing Life Again

A handful of stocks benefited massively during the pandemic. It was an interesting time to be an investor, to say the least, and those who targeted the stay-at-home stocks were rewarded handsomely

Jittery? Here's How to Profit from Today's Market
Jittery? Here's How to Profit from Today's Market

The Nasdaq entered a new bull market in a flash, soaring 24% from its early April lows, with the S&P 500 on the cusp (+17%).Plenty of investors missed this rally for various reasons, from attempting

RE/MAX Expands Footprint With New Master Franchise & Office Launch
RE/MAX Expands Footprint With New Master Franchise & Office Launch

RE/MAX Holdings, Inc. RMAX recently announced the sale of master franchise rights in Côte d'Ivoire, enhancing its presence across Western Africa and the opening of a franchised brokerage in Bahrain

U.S. Stocks Rebound Sharply in May: Can the Rally Continue?
U.S. Stocks Rebound Sharply in May: Can the Rally Continue?

U.S. equities have posted strong gains in May, with the S&P 500 rising more than about 15% from its lows in April. Markets have stabilized following a temporary truce in U.S.-China trade tensions

3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL)
3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL)

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth

3 Reasons Growth Investors Will Love DHL Group Sponsored ADR (DHLGY)
3 Reasons Growth Investors Will Love DHL Group Sponsored ADR (DHLGY)

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Looking for a Growth Stock? 3 Reasons Why Interface (TILE) is a Solid Choice
Looking for a Growth Stock? 3 Reasons Why Interface (TILE) is a Solid Choice

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Is Andritz (ADRZY) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is Andritz (ADRZY) a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth

Is Quanta Services (PWR) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is Quanta Services (PWR) a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

IBM vs. Accenture: Which Stock Stands Out in the Consulting Game?
IBM vs. Accenture: Which Stock Stands Out in the Consulting Game?

International Business Machines Corporation IBM and Accenture ACN are major players in the digital transformation and consulting space worldwide. IBM’s Consulting business focuses on designing

Should You Hold on to RDDT Despite the Stock's 39% YTD Decline?
Should You Hold on to RDDT Despite the Stock's 39% YTD Decline?

Reddit RDDT shares have plunged 38.8% in the year-to-date period, underperforming the broader Zacks Computer & Technology sector’s decline of 2.6%. The Zacks Internet - Software industry increased

Earnings Estimates Moving Higher for Exelixis (EXEL): Time to Buy?
Earnings Estimates Moving Higher for Exelixis (EXEL): Time to Buy?

Investors might want to bet on Exelixis (EXEL), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and

Is Unum Group Stock Worth Buying Post its Recent Dividend Hike
Is Unum Group Stock Worth Buying Post its Recent Dividend Hike

Unum Group’s UNM board of directors recently approved a 10% hike in its dividend to $1.84 per share or 46 cents per share quarterly. The meatier dividend will be paid out in the third quarter of

Why Brown-Forman B (BF.B) is Poised to Beat Earnings Estimates Again
Why Brown-Forman B (BF.B) is Poised to Beat Earnings Estimates Again

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Brown-Forman B (BF.B), which belongs to the

Will Royal Bank (RY) Beat Estimates Again in Its Next Earnings Report?
Will Royal Bank (RY) Beat Estimates Again in Its Next Earnings Report?

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Royal Bank (RY), which belongs to the Zacks

Why J.Jill (JILL) Could Beat Earnings Estimates Again
Why J.Jill (JILL) Could Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? J.Jill (JILL), which belongs to the

Mondelez (MDLZ) Upgraded to Strong Buy: Here's What You Should Know
Mondelez (MDLZ) Upgraded to Strong Buy: Here's What You Should Know

Mondelez (MDLZ) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one

What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock
What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock

Investors might want to bet on Eledon Pharmaceuticals, Inc. (ELDN), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings